top of page

Mwandishi

Mhariri:

Imeboreshwa:

< Orodha kuu

ULY CLINIC

ULY CLINIC

Jumanne, 14 Julai 2026, 12:55:47 UTC

Shigellosis Management

Shigellosis management


Definition

Shigellosis is an acute intestinal infection caused by Shigella species, which are gram-negative facultative intracellular bacterial pathogens.

The four major species are:

  • Shigella dysenteriae (Group A)

  • Shigella flexneri (Group B)

  • Shigella boydii (Group C)

  • Shigella sonnei (Group D)

Transmission occurs through the faecal-oral route, typically by ingestion of contaminated food or water. The disease commonly results in bacillary dysentery.


Clinical presentation

  • Acute abdominal cramping

  • High-grade fever

  • Vomiting (emesis)

  • Large-volume watery diarrhoea

  • Tenesmus

  • Urgency

  • Faecal incontinence

  • Mucoid bloody diarrhoea

  • Severe headache

  • Lethargy

  • Meningismus

  • Delirium

  • Convulsions

  • Profound dehydration

  • Hypoglycaemia


Severe complications

  • Hemolytic uremic syndrome (HUS)

  • Microangiopathic hemolytic anaemia

  • Thrombocytopenia

  • Acute renal failure


Investigations

Microbiological diagnosis

  • Isolation of Shigella organisms from:

    • Stool specimens

    • Rectal swab specimens

Culture

  • Stool culture for suspected cases, especially during the early course of infection


Toxin detection

  • ELISA for Shiga toxin detection in stool specimens, particularly for Shigella dysenteriae type I


Pharmacological treatment

Ciprofloxacin

  • Dose: 500 mg

  • Route: Oral (PO)

  • Frequency: Every 12 hours

  • Duration: 5 days

OR


Erythromycin

  • Dose: 500 mg

  • Route: Oral (PO)

  • Frequency: Every 6 hours

  • Duration: 5 days


Monitoring

  • Monitor hydration status

  • Monitor stool frequency and severity

  • Monitor for signs of dehydration

  • Monitor renal function in severe disease

  • Monitor for neurological complications

  • Monitor for development of hemolytic uremic syndrome


Possible complications

  • Bacillary dysentery

  • Profound dehydration

  • Hypoglycaemia

  • Convulsions

  • Delirium

  • Hemolytic uremic syndrome

  • Microangiopathic hemolytic anaemia

  • Thrombocytopenia

  • Acute renal failure


Follow-up

  • Reassess symptoms after completion of treatment.

  • Evaluate for persistent diarrhoea or ongoing dehydration.

  • Investigate for complications if symptoms worsen or fail to improve.

Imeandikwa:

Jumatatu, 1 Juni 2026, 16:38:44 UTC

References:

bottom of page